<!DOCTYPE html>

<html lang="en">
<head>
	<meta charset="utf-8">
	<meta name="viewport" content="width=device-width, initial-scale=1">
	<title></title>
	<link rel="stylesheet" href="css/ka.css" type="text/css" />
	<link rel="stylesheet" href="css/lr.css" type="text/css" />
	<link rel="stylesheet" href="css/animate.css" type="text/css" />
	<script type="text/javascript" src="js/base.js"></script>
	<script type="text/javascript" charset="utf-8">
		
		var ANIMATION = [
			stagger(flip('.box'), '.subtext'),
			['#legend', '#chart1'],
			['.bar'],
			['.number', '#lines']
		];
		
	</script>
</head>
<body class="popup-16-1">
	<!--<div id="popup">-->
		<div style=" background: #FFF; color: #000;height: 450px; width: 960px; padding:5px 0 0 10px">		
        <ol>
        <li><span>KALETRA [package insert]. North Chicago, IL: AbbVie Inc.</span></li>
        <li><span>Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Department of Health and Human Services. January 10, 2011; 1-166. Available at: http://www.aidsinfo.nih.gov/ContentFiles/Adultand AdolescentGL.pdf. Accessed January 11, 2011; 43. </span></li>
        <li><span>Panel on Treatment of HIV-Infected Pregnant Women and Prevention of Perinatal Transmission. Recommendations for use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV transmission in the United States. May 24, 2010; 1-117. Available at: http://aidsinfo.nih.gov/ContentFiles/PerinatalGL.pdf. Accessed July 19, 2010; 41.</span></li>
        <li><span>Gathe J, da Silva BA, Cohen DE, et al. A once-daily lopinavir/ritonavir-based regimen is noninferior to twice-daily dosing and results in similar safety and tolerability in antiretroviral-na√Øve subjects through 48 weeks. <em>J Acquir Immune Defic Syndr.</em> 2009;50:474-481.</span></li>
        <li><span>Data on file. AbbVie Inc.</span></li>
        <li><span>National Heart, Lung, and Blood Institute website. ATP III guidelines at-a-glance quick desk reference. National Cholesterol Education Program. Available at: http://www.nhlbi.nih.gov/guidelines/cholesterol/atglance.pdf. Accessed July 28, 2010.</span></li>
        </ol>
	</div>
</body>
</html>
